Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+11.3%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$52.3B
AUM Growth
+$4.34B
(+9%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79
Top Buys
| 1 |
Tesla
TSLA
|
+$125M |
| 2 |
Home Depot
HD
|
+$110M |
| 3 |
Verizon
VZ
|
+$109M |
| 4 |
IS
ironSource Ltd.
IS
|
+$107M |
| 5 |
Pfizer
PFE
|
+$105M |
Top Sells
| 1 |
AT&T
T
|
+$246M |
| 2 |
Intel
INTC
|
+$218M |
| 3 |
Ford
F
|
+$164M |
| 4 |
Micron Technology
MU
|
+$149M |
| 5 |
General Motors
GM
|
+$144M |
Sector Composition
| 1 | Technology | 25.17% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.2% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Communication Services | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Enerpac Tool Group
EPAC
$2.31B
| $375K | ﹤0.01% |
18,514
-33,040
| -64% | -$669K |
|
1727
Cameco
CCJ
$34.8B
| $373K | ﹤0.01% |
17,100
| – | – |
|
1728
World Acceptance Corp
WRLD
$912M
| $373K | ﹤0.01% |
1,520
-6,580
| -81% | -$1.61M |
|
|
DCPH
1729
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $373K | ﹤0.01% |
+38,180
| New | +$373K |
|
1730
Lemonade
LMND
$3.7B
| $372K | ﹤0.01% |
+8,830
| New | +$372K |
|
|
HMHC
1731
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $372K | ﹤0.01% |
+23,090
| New | +$372K |
|
1732
Open Lending Corp
LPRO
$252M
| $370K | ﹤0.01% |
+16,450
| New | +$370K |
|
1733
OneMain Financial
OMF
$7.25B
| $370K | ﹤0.01% |
7,395
-41,955
| -85% | -$2.1M |
|
1734
Rocket Companies
RKT
$44B
| $370K | ﹤0.01% |
+26,400
| New | +$370K |
|
1735
Par Pacific Holdings
PARR
$1.7B
| $369K | ﹤0.01% |
22,350
-33,450
| -60% | -$552K |
|
1736
LeMaitre Vascular
LMAT
$2.09B
| $367K | ﹤0.01% |
7,300
| – | – |
|
1737
Southern Copper
SCCO
$82.4B
| $367K | ﹤0.01% |
6,248
| – | – |
|
1738
Teva Pharmaceuticals
TEVA
$22.4B
| $367K | ﹤0.01% |
45,850
+1,500
| +3% | +$12K |
|
1739
Core Laboratories
CLB
$582M
| $366K | ﹤0.01% |
16,396
-116,710
| -88% | -$2.61M |
|
1740
Protagonist Therapeutics
PTGX
$3.59B
| $365K | ﹤0.01% |
+10,680
| New | +$365K |
|
1741
eHealth
EHTH
$118M
| $363K | ﹤0.01% |
14,246
-5,170
| -27% | -$132K |
|
1742
Bausch Health
BHC
$2.67B
| $362K | ﹤0.01% |
13,100
| – | – |
|
|
FARO
1743
DELISTED
Faro Technologies
FARO
| $361K | ﹤0.01% |
5,160
-10,490
| -67% | -$734K |
|
1744
Kaiser Aluminum
KALU
$1.22B
| $361K | ﹤0.01% |
3,845
-11,590
| -75% | -$1.09M |
|
1745
ANI Pharmaceuticals
ANIP
$2.12B
| $359K | ﹤0.01% |
7,793
-5,390
| -41% | -$248K |
|
|
CMRX
1746
DELISTED
Chimerix, Inc.
CMRX
| $357K | ﹤0.01% |
+55,570
| New | +$357K |
|
1747
Century Aluminum
CENX
$2.09B
| $355K | ﹤0.01% |
21,430
-14,970
| -41% | -$248K |
|
1748
CryoPort
CYRX
$489M
| $355K | ﹤0.01% |
+6,000
| New | +$355K |
|
1749
Herc Holdings
HRI
$4.45B
| $355K | ﹤0.01% |
+2,270
| New | +$355K |
|
1750
Astec Industries
ASTE
$1.06B
| $354K | ﹤0.01% |
5,110
-17,440
| -77% | -$1.21M |
|